Network pharmacology and experimental validation to reveal the pharmacological mechanisms of Qizhu prescription for treating breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Network pharmacology and experimental validation to reveal the pharmacological mechanisms of Qizhu prescription for treating breast cancer

Published:2024-07 Issue:3 Volume:11 Page:303-315
ISSN:2095-7548
Container-title:Journal of Traditional Chinese Medical Sciences
language:en
Short-container-title:Journal of Traditional Chinese Medical Sciences

Author:

Sheng Jiayu^ORCID,Cheng Junyi,Chu Wenjie,Dong Mengting,Jiang Ke^ORCID

Publisher

Elsevier BV

Reference55 articles.

1. Cancer incidence and mortality in China, 2022;Zheng;Chin J Oncol,2024

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Guizhi Fuling decoction inhibiting the PI3K and MAPK pathways in breast cancer cells revealed by HTS2 technology and systems pharmacology;Dai;Comput Struct Biotechnol J,2020

4. Scutellaria barbata and hedyotis diffusa herb pair for breast cancer treatment: potential mechanism based on network pharmacology;Ma;J Ethnopharmacol,2020

5. The mechanism of action of Fangji Huangqi decoction on epithelial-mesenchymal transition in breast cancer using high-throughput next-generation sequencing and network pharmacology;Guo;J Ethnopharmacol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP